Form 4 for CTSO Cytosorbents Corp

Accepted 2022-05-12 00:00:00 ET · period of report 2022-05-11 · accession 0001104659-22-059474 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2022-05-12	2022-05-11	CTSO	Sobel Alan D.	Dir	P - Purchase	$2.02	+10.0K	70.5K	+17%	+$20.2K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-05-11	P	A	8,800	$2.02	79,300	D	—	—	(F1) Includes (i) the following restricted stock units that will be settled into common stock upon vesting upon a "Change in Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"): (a) 3,300 restricted stock units granted on March 15, 2018, (b) 6,000 restricted stock units granted on February 24, 2017, (c) 5,000 restricted stock units granted on June 7, 2016, and (d) 55,000 restricted stock units granted on April 8, 2015 and (ii) 10,000 shares of common stock purchased by the reporting person on May 11, 2022 and reported on this Form 4.
2	Common	Common Stock	2022-05-11	P	A	1,200	$2.00	70,500	D	—	—